<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:20:01Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5955780" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5955780</identifier>
        <datestamp>2018-05-17</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">9815831</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">22061</journal-id>
              <journal-id journal-id-type="nlm-ta">Genet Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Genet. Med.</journal-id>
              <journal-title-group>
                <journal-title>Genetics in medicine : official journal of the American College of Medical Genetics</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1098-3600</issn>
              <issn pub-type="epub">1530-0366</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5955780</article-id>
              <article-id pub-id-type="pmcid">PMC5955780</article-id>
              <article-id pub-id-type="pmc-uid">5955780</article-id>
              <article-id pub-id-type="pmid">29758564</article-id>
              <article-id pub-id-type="pmid">29758564</article-id>
              <article-id pub-id-type="doi">10.1038/gim.2017.150</article-id>
              <article-id pub-id-type="manuscript">nihpa897685</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Monogenic Diabetes in Overweight and Obese Youth Diagnosed with Type
2 Diabetes: The TODAY Clinical Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kleinberger</surname>
                    <given-names>Jeffrey W.</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Copeland</surname>
                    <given-names>Kenneth C.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gandica</surname>
                    <given-names>Rachelle G.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Haymond</surname>
                    <given-names>Morey W.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Levitsky</surname>
                    <given-names>Lynne L.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Linder</surname>
                    <given-names>Barbara</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="A6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shuldiner</surname>
                    <given-names>Alan R.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref ref-type="aff" rid="A7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tollefsen</surname>
                    <given-names>Sherida</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>White</surname>
                    <given-names>Neil H.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="A9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pollin</surname>
                    <given-names>Toni I.</given-names>
                  </name>
                  <degrees>MS, PhD</degrees>
                  <xref ref-type="aff" rid="A1">1</xref>
                  <xref rid="FN1" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <collab>for the TODAY Study Group</collab>
                  <xref rid="FN1" ref-type="author-notes">†</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>1</label>Division of Endocrinology, Diabetes, and Nutrition, Department of
Medicine, University of Maryland School of Medicine, Baltimore, MD</aff>
              <aff id="A2"><label>2</label>University of Oklahoma College of Medicine, Oklahoma City, OK</aff>
              <aff id="A3"><label>3</label>Naomi Berrie Diabetes Center, Columbia University Medical Center,
New York, NY</aff>
              <aff id="A4"><label>4</label>Baylor College of Medicine, Houston, TX</aff>
              <aff id="A5"><label>5</label>Massachusetts General Hospital, Harvard Medical School, Boston,
MA</aff>
              <aff id="A6"><label>6</label>Division of Diabetes, Endocrinology and Metabolic Diseases, National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD</aff>
              <aff id="A7"><label>7</label>Regeneron Genetics Center, Regeneron, Tarrytown, NY</aff>
              <aff id="A8"><label>8</label>Saint Louis University Health Sciences Center, St. Louis, MO</aff>
              <aff id="A9"><label>9</label>Washington University School of Medicine, St. Louis, MO</aff>
              <author-notes>
                <corresp id="FN1"><label>*</label>Address for correspondence: Toni I. Pollin, M.S., Ph.D.,
University of Maryland School of Medicine, 660 West Redwood Street, Room 445C,
Baltimore, MD 21201.; <email>tpollin@medicine.umaryland.edu</email></corresp>
                <fn id="FN2">
                  <label>†</label>
                  <p>A listing of the TODAY Study Group can be found in the <xref ref-type="supplementary-material" rid="SD1">online appendix</xref></p>
                </fn>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>11</day>
                <month>8</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>12</day>
                <month>10</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>6</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>17</day>
                <month>5</month>
                <year>2018</year>
              </pub-date>
              <volume>20</volume>
              <issue>6</issue>
              <fpage>583</fpage>
              <lpage>590</lpage>
              <!--elocation-id from pubmed: 10.1038/gim.2017.150-->
              <permissions>
                <license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">
                  <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="S1">
                  <title>Purpose</title>
                  <p id="P1">Monogenic diabetes accounts for 1–2% of diabetes
cases. It is often undiagnosed, which may lead to inappropriate treatment.
This study was performed to estimate the prevalence of monogenic diabetes in
a cohort of overweight/obese adolescents diagnosed with type 2 diabetes
(T2D).</p>
                </sec>
                <sec id="S2">
                  <title>Methods</title>
                  <p id="P2">Sequencing using a custom monogenic diabetes gene panel was performed
on a racially/ethnically diverse cohort of 488 overweight/obese adolescents
with T2D in the TODAY clinical trial. Associations between having a
monogenic diabetes variant and clinical characteristics and time to
treatment failure were analyzed.</p>
                </sec>
                <sec id="S3">
                  <title>Results</title>
                  <p id="P3">Over four percent (22/488) had genetic variants causing monogenic
diabetes (7 <italic>GCK</italic>, 7 <italic>HNF4A</italic>, 5
<italic>HNF1A</italic>, 2 <italic>INS</italic>, and 1
<italic>KLF11</italic>). Patients with monogenic diabetes had a
statistically, but not clinically, significant lower BMI Z-score, lower
fasting insulin, and higher fasting glucose. Most (6/7) patients with
<italic>HNF4A</italic> variants rapidly failed TODAY treatment across
study arms (HR=5.03, p=0.0002), while none with
<italic>GCK</italic> variants failed treatment.</p>
                </sec>
                <sec id="S4">
                  <title>Conclusions</title>
                  <p id="P4">Discovery of 4.5% of patients with monogenic diabetes in an
overweight/obese cohort of children and adolescents with T2D suggests
monogenic diabetes diagnosis should be considered in children and
adolescents without diabetes-associated autoantibodies and maintained
C-peptide, regardless of BMI, as it may direct appropriate clinical
management.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>monogenic diabetes</kwd>
                <kwd>obesity</kwd>
                <kwd>youth</kwd>
                <kwd>type 2 diabetes</kwd>
                <kwd>clinical trial</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="S5">
              <title>INTRODUCTION</title>
              <p id="P5">Maturity-onset diabetes of the young (MODY), the most common category of
monogenic diabetes, results from a single variant in an individual patient in one of
14 known genes. In the 1970s, the term MODY was created to characterize patients
described by Dr. Stefan Fajans as having a non-insulin-dependent form of diabetes at
a young age.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref ref-type="fn" rid="FN3">1</xref></sup> Epidemiological studies across Europe
determined that MODY accounts for approximately 1–2% of all
diabetes.<sup><xref rid="R3" ref-type="bibr">3</xref></sup>
<italic>GCK</italic>-MODY, <italic>HNF1A</italic>-MODY, and
<italic>HNF4A</italic>-MODY account for at least 85% of MODY
cases.<sup><xref rid="R4" ref-type="bibr">4</xref>–<xref rid="R6" ref-type="bibr">6</xref></sup> MODY generally presents in an autosomal
dominant pattern of inheritance early in life as non-insulin requiring
hyperglycemia. Correct characterization of monogenic diabetes is important for
optimal patient treatment since the most common etiologies can be effectively
treated with methods different from first-line treatments for type 1 diabetes (T1D)
(insulin) or T2D (metformin). Patients with <italic>HNF1A</italic>-MODY and
<italic>HNF4A</italic>-MODY are effectively treated with oral sulfonylurea
therapy.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> Patients with <italic>GCK</italic>-MODY have
mildly elevated baseline blood glucose concentrations that commonly do not require
treatment and do not lead to diabetic complications.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Therefore, proper diagnosis of monogenic
diabetes can lead to more effective, less invasive, and less expensive treatment for
patients and potentially family members with the same variant.</p>
              <p id="P6">American Diabetes Association (ADA) guidelines suggest a diagnosis of
monogenic diabetes be considered when diabetes is diagnosed in the first 6 months of
life, when the patient does not have features of T1D (negative for
diabetes-associated antibodies) or T2D (nonobese, lacking other metabolic features)
especially when there is a strong family history of diabetes, or when there is
stable, mildly elevated fasting blood glucose.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> However, studies indicate these guidelines are either not
utilized or fail to detect many cases of monogenic diabetes. The SEARCH study for
diabetes in youth discovered that greater than 90% of patients with
<italic>GCK</italic>, <italic>HNF1A</italic>, or <italic>HNF4A</italic> variants
were misdiagnosed as T1D (36%) or T2D (51%), and only 19% of
patients with MODY variants had treatment appropriate to their etiology.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Many factors contribute to the
underdiagnosis of monogenic diabetes, including: heterogeneity of monogenic diabetes
patient characteristics, similarity between monogenic diabetes and the more common
forms of diabetes (especially with increasing prevalence of T2D in children and
adolescents), cost of genetic testing, lack of insurance reimbursement, and lack of
awareness among healthcare providers. With such high rates of overweight and obesity
in young people, one might expect common co-occurrence of a T2D phenotype with
monogenic diabetes, making currently suggested algorithms for diagnosis of monogenic
diabetes even less sensitive.</p>
              <p id="P7">Although T2D has been historically found mainly in overweight adults over age
40, recent increases in overweight or obese adolescents have led to an increased
occurrence of T2D in young populations. Because of the increasing prevalence of T2D
in adolescents and the lack of data regarding adolescent-specific T2D treatment
methods, the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY)
study analyzed the effectiveness of metformin alone or in combination with
rosiglitazone or lifestyle changes in adolescents with recently-diagnosed
T2D.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Approximately half
(48.3%) of the 699 participants treated with metformin alone maintained
glycemic control, while the combination of metformin and rosiglitazone showed a
small but significant improvement in the durability of glycemic control
(61.4% maintained control, 25.3% decrease in primary outcome
occurrence compared to metformin alone, p=0.006) over a relatively short
duration of treatment (patients were followed for an average of 3.86
years).<sup><xref rid="R13" ref-type="bibr">13</xref></sup> In our current
study, we analyze the prevalence of monogenic diabetes in the TODAY study
participants and their outcomes.</p>
            </sec>
            <sec sec-type="materials|methods" id="S6">
              <title>MATERIALS AND METHODS</title>
              <sec id="S7">
                <title>Patient Characteristics</title>
                <p id="P8">The TODAY study participants were adolescents age 10–17 diagnosed
with T2D according to ADA criteria within 2 years of study enrollment. The
protocol for the TODAY study was approved by the Institutional Review Board at
each participating institution (<ext-link ext-link-type="uri" xlink:href="ClinicalTrials.gov">ClinicalTrials.gov</ext-link>: NCT00081328),
and informed consent was obtained from all subjects. Eligibility criteria also
included: body-mass index (BMI) above the 85th percentile while accounting for
age and sex, negative for diabetes-associated autoantibodies (GAD65 and ICA512),
and fasting C-peptide ≥ 0.20 nmol/L. Following a run-in period in which
glycemic control (HbA1c &lt;8%) on metformin alone was attained,
metabolic, glycemic, anthropometric, and lifestyle attributes were collected
longitudinally from all TODAY study participants. Patients were followed
longitudinally until they lost glycemic control and reached the primary outcome
of the study, defined as a glycated hemoglobin value of at least 8.0%
for 6 consecutive months or the inability to wean the participant from insulin
within 3 months after treatment for acute metabolic decompensation. Further
descriptions of study protocol, design, methods, and results have been
previously reported.<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup></p>
                <p id="P9">This study analyzed DNA from a subset of 488 adolescents (177 males and
311 females) from the total TODAY cohort of 699 participants. Some TODAY
participants had no DNA available to analyze because they did not attend a study
visit during the DNA collection period or because they refused to consent to
provide genetic data. In addition, all participants of undefined race/ethnicity
or of a race/ethnicity with a small sample size were excluded from this
analysis. Subject data included in this analysis were Hispanic (n=217),
non-Hispanic black (NHB, n=166), or non-Hispanic white (NHW,
n=105) and showed no obvious differences from the entire TODAY cohort
with those race/ethnicities (<xref ref-type="supplementary-material" rid="SD1">Tables S1, S2</xref>).</p>
              </sec>
              <sec id="S8">
                <title>Sequencing methods</title>
                <p id="P10">Coding and flanking regions of 40 autosomal genes with variants known or
predicted to cause monogenic diabetes, including 13 genes identified to cause
MODY at the time of study design (<italic>APPL1</italic> was published as a
cause of MODY after design of our study) as well as genes causing neonatal
diabetes, diabetes syndromes, lipodystrophy, severe obesity, and
hyperinsulinemia (based on the theory that gain of function mutations could
cause diabetes), were analyzed by next-generation sequencing using a customized
gene panel (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>).
DNA amplification, barcoding, and purification were performed using the Ion
AmpliSeq Library Kit 2.0, Ion Xpress Barcode Adapter Kit, and Ion Library
Equalizer Kit (Life Technologies). Emulsion PCR was performed on the Ion One
Touch 2 using the Ion PGM Template OT2 200 Kit, and isolation of Ion Sphere
Particles with clonally amplified DNA was performed with the Ion Torrent
OneTouch ES (Life Technologies). Sequencing was performed using the Ion Torrent
Personalized Genome Machine with the Ion PGM Sequencing 200 Kit version 2 and
Ion 316 Chip version 2 (Life Technologies). Alignment was performed using TMAP
version 4.2.14 software. Variant Calling was performed using the Torrent Suite
variantCaller plugin version 4.2–14 and coverage analysis was performed
using the Torrent Suite coverageAnalysis plugin version 4.2. Only samples with
≥20x mean base coverage depth of ≥80% of the target
region (139,491bp) were used for analysis. Single-nucleotide variants with
genotype quality scores &lt;20 and coverage depth &lt;10x were
filtered from analysis, as were insertions/deletions with genotype quality
scores &lt;50 and coverage depth &lt;50x. Samples had a mean of
186,170±67,019 (s.d.) mapped reads, and the single nucleotide variant
transition to transversion ratio was 2.31. Quality metrics of monogenic diabetes
variants are included in <xref ref-type="supplementary-material" rid="SD1">Table
S4</xref>. Variants were annotated using a customized pipeline using
multiple large population datasets, <italic>in silico</italic> prediction tools,
and conservation metrics. All variants in non-coding or non-canonical splice
regions, variants with a minor allele frequency (MAF) &gt; 5.0%, or
synonymous variants were filtered from further analysis.</p>
              </sec>
              <sec id="S9">
                <title>Variant Analysis</title>
                <p id="P11">Non-common (&lt;5% MAF) coding or splice-site variants were
analyzed for pathogenicity according to American College of Medical
Genetics/Association for Molecular Pathology (ACMG/AMP) guidelines for variant
interpretation.<sup><xref rid="R14" ref-type="bibr">14</xref></sup>
These guidelines were created to standardize the complex process of classifying
variants into categories (“pathogenic,” “likely
pathogenic,” “uncertain significance,” “likely
benign,” or “benign”) based on population data,
computational data, functional data, and segregation data. Criteria (<xref ref-type="supplementary-material" rid="SD1">Table S5</xref>) were assessed
for each variant and pathogenicity was determined based on the total evidence
according to the algorithm of the ACMG/AMP guidelines.<sup><xref rid="R14" ref-type="bibr">14</xref></sup></p>
              </sec>
              <sec id="S10">
                <title>Statistical Analysis</title>
                <p id="P12">Patients were grouped for statistical analysis. The unaffected group
(n=426) did not have any pathogenic, likely pathogenic, or
previously-cited monogenic diabetes variants. Other groups included patients
with pathogenic or likely pathogenic variants in any monogenic diabetes gene
(n=22), <italic>HNF1A</italic> (n=5), <italic>HNF4A</italic>
(n=7), or <italic>GCK</italic> (n=7). Participants with
previously-cited monogenic diabetes variants that were not classified as
pathogenic or likely pathogenic (n=40) were not included in analysis due
to uncertainty over their monogenic diabetes status. Associations between
monogenic diabetes subcategories and patient characteristics, including BMI
Z-score, HbA1c, fasting glucose, fasting insulin, insulinogenic index, dual
energy x-ray absorptiometry (DXA), lipid measures, and blood pressure, were
evaluated using linear models accounting for sex, age, race, and BMI Z-score
(where indicated). These measures were collected from the earliest available
time-point for the trait (screening data for those traits where it was
available; otherwise from baseline measures). Log transformation was used to
normalize datasets with skewed distributions. Because these analyses were
hypothesis-driven, a p-value of &lt;0.05 was considered nominally
significant and no adjustment for multiple comparison testing was
performed.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Treatment
failure was defined as the primary outcome of the TODAY Study (loss of glycemic
control, defined as a glycated hemoglobin values of at least 8.0% for 6
consecutive months or the inability to wean the participant from insulin within
3 months after treatment for acute metabolic decompensation). Treatment failure
analyses were performed using a Cox proportional hazards model using the patient
outcomes specified in the original TODAY study.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> The treatment failure analysis accounted
for participant sex, age, race/ethnicity, and TODAY treatment group. The
proportional hazards assumption was met by each variable, except for sex, which
was treated as a stratifying variable in the model.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="S11">
              <title>RESULTS</title>
              <sec id="S12">
                <title>Monogenic Diabetes Gene Variants</title>
                <p id="P13">The thirteen genes reported to cause MODY at the time of study design
were analyzed for non-common coding and splice site variants in this cohort
(<xref ref-type="supplementary-material" rid="SD1">Table S6</xref>).
Twenty-six previously-cited MODY variants were assessed according to ACMG/AMP
criteria, and 18 were classified pathogenic or likely pathogenic (<xref rid="T1" ref-type="table">Table 1</xref>), while eight were classified as benign,
likely benign, or variants of uncertain significance (<xref ref-type="supplementary-material" rid="SD1">Table S7</xref>). Thirty novel
variants were discovered, and four of those variants were classified as
pathogenic or likely pathogenic, while 26 were variants of uncertain
significance (<xref ref-type="supplementary-material" rid="SD1">Table
S8</xref>). Patients with pathogenic or likely pathogenic variants were
considered to have monogenic diabetes. In sum, 22 individuals with 22 different
pathogenic or likely pathogenic variants were discovered; i.e. 22/488 of those
analyzed, or 4.5% of this sample of TODAY participants, had monogenic
diabetes. Patients with monogenic diabetes were found across each of the three
categories of race/ethnicity and across all treatment arms of the TODAY clinical
trial (<xref rid="T1" ref-type="table">Table 1</xref>, <xref ref-type="supplementary-material" rid="SD1">S2</xref>). While variants were
found in non-MODY genes in this study, none were determined to be pathogenic or
likely pathogenic for monogenic diabetes or monogenic forms of obesity (<xref ref-type="supplementary-material" rid="SD1">Table S9</xref>).</p>
              </sec>
              <sec id="S13">
                <title>Characteristics of Patients with Monogenic Diabetes Gene Variants and Study
Outcomes</title>
                <p id="P14">Characteristics at the earliest available time-point (BMI Z-score,
HbA1c, blood pressure, triglycerides, and lipid measures were from the screening
visit, while fasting glucose, fasting insulin, insulinogenic index, and DXA
measures were from the baseline visit) of subjects with pathogenic or likely
pathogenic monogenic diabetes variants (n=22) were compared to those
without monogenic diabetes (n=426) (<xref rid="T2" ref-type="table">Table 2</xref>, <xref ref-type="supplementary-material" rid="SD1">S10</xref>). Individuals with monogenic diabetes showed lower BMI Z-scores
(2.05 vs. 2.32 p=0.004), higher fasting glucose (6.65 vs. 6.08 mmol/L
p=0.02), lower fasting insulin (152.1 vs. 213.91 pmol/L p=0.03)
and higher total cholesterol (4.50 vs. 4.00 mmol/L p=0.003) compared to
individuals without monogenic diabetes. These associations were still
significant when adjusted for BMI Z-score (<xref ref-type="supplementary-material" rid="SD1">Table S10</xref>). Separated by
gene etiology, monogenic diabetes subgroups showed similar trends in patient
characteristics, although they were generally underpowered to detect significant
differences.</p>
                <p id="P15">Time-to-treatment failure analyses, the primary outcome of the TODAY
Study, compared unaffected individuals (n=426) with individuals with
<italic>HNF1A</italic>-MODY, <italic>HNF4A</italic>-MODY, and
<italic>GCK</italic>-MODY (<xref rid="F1" ref-type="fig">Figure 1</xref>).
No patients with <italic>GCK</italic>-MODY (0/7) failed treatment in the TODAY
study. Across all three study arms, 6 of 7 of the subjects with
<italic>HNF4A</italic>-MODY failed treatment over the first 2 years of
study, with a hazard ratio of 5.03 (2.18–11.58 95%CI)
(p=0.0002) compared to subjects without monogenic diabetes. Three
patients with <italic>HNF4A</italic>-MODY lost glycemic control by their first
post-baseline study visit. There was no significant difference in treatment
response of individuals with <italic>HNF1A</italic>-MODY compared to individuals
without monogenic diabetes.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="S14">
              <title>DISCUSSION</title>
              <p id="P16">Based on our findings, an appreciable number of youth diagnosed with T2D
may, in fact, have undiagnosed monogenic diabetes. Individuals with monogenic
diabetes participating in TODAY displayed subtle, but significant, differences in
select characteristics compared to unaffected TODAY participants. However, in this
adolescent population sample selected for being overweight or obese and having
non-autoimmune, C-peptide positive diabetes, it was not possible to reliably
distinguish between T2D and monogenic diabetes based on clinical features at
baseline in this study. Importantly, patients with monogenic diabetes were found in
each race/ethnicity examined, emphasizing that race/ethnicity should not be used to
discriminate between those with and without monogenic diabetes. We also confirmed
the importance of a genetic diagnosis of monogenic diabetes to inform treatment
protocols since metformin, while the first line treatment of T2D, was ineffective in
those who turned out to have <italic>HNF4</italic>-MODY. Further emphasizing the
known relationship between genetic diagnosis and established treatment protocols,
those with <italic>GCK</italic>-MODY did not fail treatment, since patients with
<italic>GCK</italic>-MODY do not generally have highly elevated HbA1c and
typically do not require drug therapy. Both of these findings have strong
implications for clinical practice.</p>
              <p id="P17">At least 4.5% of TODAY participants (22/488) had pathogenic or
likely pathogenic monogenic diabetes variants (<xref rid="T1" ref-type="table">Table
1</xref>). It is estimated that there are approximately 3,700 new diagnoses of
T2D in youth each year in the United States, and our findings suggest as many as 160
of those cases could be misdiagnosed cases of monogenic diabetes.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> The SEARCH study for diabetes in
youth previously found 8% of participants with diabetes-associated
autoantibody-negative, C-peptide positive diabetes had monogenic diabetes variants
in <italic>GCK</italic>, <italic>HNF1A</italic>, and
<italic>HNF4A</italic>.<sup><xref rid="R11" ref-type="bibr">11</xref></sup>
Similar to the SEARCH study, we found no differences in family history of diabetes,
as measured by reported maternal and paternal diabetes status, between TODAY
patients with or without monogenic diabetes, and we found comparable racial/ethnic
distributions of patients with monogenic diabetes between TODAY and SEARCH (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). We probably found
a lower percentage of patients with monogenic diabetes because the TODAY study
eligibility criteria required adolescents with diabetes to be overweight or obese.
Additionally, it is possible for individuals to have monogenic diabetes and
coincident insulin resistance or T2D, which can further complicate both diagnosis
and treatment. While likely to only account for a minority of cases, patients with
authentic T1D or T2D harboring monogenic diabetes variants have been described
before.<sup><xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup></p>
              <p id="P18">By following the ACMG/AMP guidelines for variant annotation, our study has
potentially limited our estimation of the prevalence of monogenic diabetes in the
cohort. While the ACMG/AMP guidelines are important for correctly classifying
clinical implications of variants before being returned to patients, the need for
evidence across multiple categories (functional studies, family co-segregation data,
<italic>de novo</italic> status, etc.) can be restrictive, especially for
recently-discovered variants. As shown in previous studies, this standardized
variant classification process often reclassifies variants previously assumed to be
pathogenic as benign, likely benign, or variants of uncertain significance (VUS) due
to increases in genetic and phenotypic database information.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Patients with “reclassified”
variants were excluded from our statistical analysis, but separate analysis of
clinical characteristics of carriers of the <italic>BLK</italic> p.A71T and
<italic>KLF11</italic> p.T220M variants showed no differences from those without
monogenic diabetes (data not shown). Analysis of 18 VUS discovered (11 novel
variants) in the 3 most common MODY genes showed patients with VUS were intermediate
or close to the monogenic diabetes group in terms of clinical characteristics (BMI
Z-score =2.27±0.48, fasting glucose =6.72±1.57
mmol/L, fasting insulin =173±123 pmol/L, mean ±s.d.), but
differences from those without monogenic diabetes (n=412 in this analysis)
were not statistically significant. This finding supports the hypothesis that at
least some of the VUS may cause monogenic diabetes. Since the ACMG/AMP guidelines
often classify novel variants as VUS due to the lack of evidence to suggest the
variant is either pathogenic or benign, further study of the novel variants found in
this study is a potentially fruitful topic for future research and could increase
the estimate of monogenic diabetes prevalence in this study.</p>
              <p id="P19">Although pathogenic and likely pathogenic monogenic diabetes genetic
variants were found in each race/ethnicity, a higher proportion of NHW participants
carried monogenic diabetes variants (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). Similarly, more NHB participants carried
previously-cited monogenic diabetes variants reclassified as VUS, likely benign, or
benign variants. The odds ratio for NHB participants carrying reclassified variants
was 2.15 compared to NHW, 3.84 compared to HIS, and 3.10 compared to the combined
NHW and HIS populations. We hypothesize this trend is due to the reliance of the
ACMG/AMP standards and guidelines on previously published data on genetic variants.
Previous monogenic diabetes studies have mainly focused on European populations,
which could cause bias in classifying variants. Underrepresentation of minority
populations in genetic studies is a well-known concern that must be addressed in
order for precision genetic medicine to be effective across all races/ethnicities.
At this point, it is important to recognize that monogenic diabetes variants can and
have been found across multiple different races/ethnicities.</p>
              <p id="P20">Through the design of the gene panel, we have potentially limited discovery
of patients with monogenic diabetes in this cohort. Since there have been relatively
few reported pathogenic variants in the 27 non-MODY genes compared to the number of
reported pathogenic MODY gene variants, coding variants in non-MODY genes are less
likely to be classified as pathogenic or likely pathogenic. Although the discovery
of more pathogenic or likely pathogenic variants in less common monogenic diabetes
genes may increase in the future, because we were unable to define any likely
pathogenic or pathogenic variants in non-MODY monogenic diabetes genes,
MODY-specific gene panels may be a more appropriate approach for future studies
screening for monogenic diabetes at this time. Also, there are potentially other
unknown causative monogenic diabetes genes or non-exonic/splicing variants not
assessed by using our gene panel.</p>
              <p id="P21">We found a larger proportion of individuals with <italic>HNF4A</italic>-MODY
than expected in our cohort (<xref rid="T1" ref-type="table">Table 1</xref>). While
<italic>HNF1A</italic>-MODY accounts for approximately 30–50% of
MODY diagnoses and <italic>HNF4A</italic>-MODY accounts for less than 10%,
we observed more patients with <italic>HNF4A</italic>-MODY than with
<italic>HNF1A</italic>-MODY.<sup><xref rid="R20" ref-type="bibr">20</xref></sup>
Interestingly, <italic>HNF4A</italic>-MODY has been associated with increased birth
weight and macrosomia in the neonatal stage, regardless of maternal genotype but
exacerbated by the mother having the same mutation and the associated hyperglycemic
intrauterine environment.<sup><xref rid="R21" ref-type="bibr">21</xref></sup>
Macrosomia has been correlated with overweight or obese status through adolescence
and adulthood.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Thus there could
be an association between <italic>HNF4A</italic>-MODY with higher BMI that could
cause <italic>HNF4A</italic>-MODY to be misdiagnosed as T2D when using BMI as a
criterion for monogenic diabetes. We hypothesize that the TODAY study inclusion
criteria (BMI ≥ 85<sup>th</sup> percentile for age and sex) may have created
a selection bias toward <italic>HNF4A</italic>-MODY compared to the other
gene-specific subgroups; however, this remains to be demonstrated. Further studies
incorporating birthweight and prevalence of T2D misdiagnosis of patients with
<italic>HNF4A</italic>-MODY are necessary to test this hypothesis.</p>
              <p id="P22">We did not discover any clinical criteria to differentiate overweight or
obese adolescents with monogenic diabetes from those with T2D in this cohort
selected for overweight or obese status and non-autoimmune, C-peptide positive
diabetes. Individuals with monogenic diabetes had lower BMI Z-score
(p=0.004), but all 22 adolescents with monogenic diabetes were still
overweight (&gt;85<sup>th</sup> percentile by age) per the TODAY study design.
For each of the clinical characteristics measured in the TODAY study, values of
patients with monogenic diabetes could be found throughout the range of values for
patients with T2D (<xref rid="T2" ref-type="table">Table 2</xref>). The functional
effects of genetic defects leading to an insulin secretion deficit were demonstrated
as adolescents with monogenic diabetes had lower fasting plasma insulin
(p=0.03) compared to those without monogenic diabetes. They also had higher
fasting blood glucose (p=0.02) concentrations. Similar to published studies
on populations with broader patient demographics, our patients with monogenic
diabetes have greater insulin sensitivity (defined as the inverse of the fasting
insulin) compared to those in our cohort with apparent T2D, but characteristics such
as HDL cholesterol and beta cell function (insulinogenic index) were not different
between the groups in this specific cohort selected by overweight/obese status and
non-autoimmune diabetes.<sup><xref rid="R23" ref-type="bibr">23</xref>–<xref rid="R25" ref-type="bibr">25</xref></sup> In summary, within this cohort of
overweight/obese autoantibody-negative, C-peptide positive diabetic cohort, there
were differences in the means of some metabolic characteristics, but it was not
possible to identify any characteristics to reliably distinguish between those with
and without monogenic etiologies. Other markers shown to help identify patients with
monogenic diabetes, such as high-sensitivity C-reactive protein and plasma glycan
profile, were not collected in the TODAY study.</p>
              <p id="P23">Although the TODAY study provided unique information about the effectiveness
of metformin alone or in combination with rosiglitazone or lifestyle changes, the
small numbers of patients with each gene subtype of monogenic diabetes reduced our
ability to draw conclusions regarding response to each of the treatment arms.
However, none of the patients with <italic>GCK</italic>-MODY failed the treatment
regimens in the TODAY study. This is consistent with the <italic>GCK</italic>-MODY
phenotype of mildly elevated fasting blood glucose (fasting glucose of
5.49–8.66 mmol/L and HbA1c of 5.6–7.6%) that usually needs
no treatment to avoid chronic complications of diabetes. In contrast, 6 of 7
patients with <italic>HNF4A</italic>-MODY failed treatment across study arms
(HR=5.03 p=0.0002), indicating poor response regardless of therapies
offered in the TODAY study. Similarly, though not statistically significant, 3/5
patients with <italic>HNF1A</italic>-MODY failed the TODAY study treatments. These
results would be expected since the established treatment for
<italic>HNF1A</italic>- and <italic>HNF4A</italic>-MODY are sulfonylurea drugs,
rather than metformin and/or rosiglitazone.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> Metformin is an
insulin-sensitizing agent, while sulfonylureas are insulin secretagogues that
improve the insulin secretion deficit found in <italic>HNF1A</italic>- and
<italic>HNF4A</italic>-MODY patients. Therefore the finding that
<italic>HNF4A</italic>-MODY patients failed metformin treatments in the TODAY
trial is a demonstration of the consequences of not attaining a genetic diagnosis of
MODY. We note that it is possible that in addition to sulfonylureas, metformin
and/or thiazolidinediones may be appropriate for some monogenic diabetes patients
with concomitant obesity and insulin resistance.</p>
              <p id="P24">Genetic testing is not commonly implemented in diabetes clinical care due to
current costs of testing, uncertainty over insurance reimbursement, and difficulty
of interpretation of sequencing results. However, clinical care is moving into an
era of genomic medicine, and monogenic diabetes provides a unique opportunity for
immediate implementation of personalized genomic medicine. Under specific conditions
of cost and discovery rate, genetic testing for MODY has been modeled to be as
cost-effective as current medical practices and potentially cost-saving.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> As the cost and throughput of
genetic testing continues to improve, the knowledge base of rare genetic variation
will continue to grow to inform clinical practice. Although current impediments to
genetic testing such as cost, availability, and reimbursement may limit genetic
testing for monogenic diabetes in large populations, this study has shown monogenic
diabetes should be considered as a possible diagnosis in young people with
antibody-negative and C-peptide positive diabetes. However, it is also important to
recognize that T2D is the most common form of diabetes in the world, and most
overweight/obese individuals with diabetes will have T2D, especially those not
diagnosed at a young age (&gt;30 years old).</p>
              <p id="P25">The findings from this study have strong implications for informing the
practice of managing diabetes in youth. We discovered individuals with monogenic
diabetes across all races/ethnicities in a cohort of overweight and obese
adolescents diagnosed with T2D, raising concerns about the currently recommended use
of BMI and previously recommended use of race/ethnicity to select patients for
genetic testing. We suggest that with secular trends of increasing obesity in
children and adolescents, monogenic diabetes be considered as a potential etiology
in diabetes-associated autoantibody-negative and C-peptide-positive adolescents
regardless of BMI. Despite the small sample size of our cohort, treatment response
based on monogenic diabetes diagnosis was consistent with predicted results,
indicating the importance of monogenic diabetes genetic testing and proper genetic
interpretation for providing optimal treatment to youth with diabetes.</p>
            </sec>
            <sec sec-type="supplementary-material" id="S15">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="SD1">
                <label>Supplementary _Appendix_ online only material_ etc._</label>
                <media xlink:href="NIHMS897685-supplement-Supplementary___Appendix__online_only_material__etc__.docx" orientation="portrait" xlink:type="simple" id="d36e727" position="anchor"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="S16">
              <p>The TODAY Study Group thanks the following companies for donations in support of the
efforts of the clinical trial: Becton, Dickinson and Company; Bristol-Myers Squibb;
Eli Lilly and Company; GlaxoSmithKline; LifeScan, Inc.; Pfizer; and Sanofi.</p>
              <p>Funding:</p>
              <p>This work was completed with funding from the National Institute of Diabetes and
Digestive and Kidney Diseases and the National Institutes of Health Office of the
Director (OD) through grants U01-DK-61212, U01-DK-61230, U01-DK-61239, U01-DK-61242,
and U01-DK-61254; from the National Center for Research Resources General Clinical
Research Centers Program grants M01-RR-00036 (Washington University School of
Medicine in St. Louis), M01-RR00043-45 (Children’s Hospital Los Angeles),
M01-RR00069 (University of Colorado Denver), M01-RR00084 (Children’s
Hospital of Pittsburgh), M01-RR01066 (Massachusetts General Hospital), M01-RR00125
(Yale University), and M01-RR14467 (University of Oklahoma Health Sciences Center);
and from the National Center for Research Resources Clinical and Translational
Science Awards UL1-RR-024134 (Children’s Hospital of Philadelphia),
UL1-RR-024139 (Yale University), UL1-RR-024153 (Children’s Hospital of
Pittsburgh), UL1-RR-024989 (Case Western Reserve University), UL1-RR-024992
(Washington University in St. Louis), UL1-RR-025758 (Massachusetts General
Hospital), and UL1-RR-025780 (University of Colorado Denver); from the National
Center for Advancing Translational Sciences grant UL1-TR-000448 (Washington
University); and from National Human Genome Research Institute grant U01-HG-007775
(University of Maryland).</p>
            </ack>
            <fn-group>
              <fn id="FN3">
                <label>1</label>
                <p>Since then, it has been suggested MODY be changed to “familial
young-onset diabetes” because of the discovery of multiple causative
genes and better understanding of the gene-specific patient characteristics
combined with the increased prevalence of type 2 diabetes (T2D) in childhood.2
While this nomenclature change is appropriate, the term MODY will be used in
this article to differentiate from other forms of monogenic diabetes, such a
neonatal or syndromic forms of monogenic diabetes, and because the term is
well-recognized by the general population.</p>
              </fn>
              <fn fn-type="COI-statement" id="FN4">
                <p>
                  <bold>Conflict of Interest</bold>
                </p>
                <p>The authors of this study have no conflicts of interest to disclose, including
consultancies, stock ownership, or other equity interests, patent licensing
arrangements and payments for conducting or publicizing a study described in the
manuscript.</p>
              </fn>
            </fn-group>
            <ref-list>
              <ref id="R1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tattersall</surname>
                      <given-names>RB</given-names>
                    </name>
                    <name>
                      <surname>Fajans</surname>
                      <given-names>SS</given-names>
                    </name>
                  </person-group>
                  <article-title>A difference between the inheritance of classical juvenile-onset
and maturity-onset type diabetes of young people</article-title>
                  <source>Diabetes</source>
                  <year>1975</year>
                  <volume>24</volume>
                  <issue>1</issue>
                  <fpage>44</fpage>
                  <lpage>53</lpage>
                  <pub-id pub-id-type="pmid">1122063</pub-id>
                </element-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murphy</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hattersley</surname>
                      <given-names>AT</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical implications of a molecular genetic classification of
monogenic beta-cell diabetes</article-title>
                  <source>Nat Clin Pract Endocrinol Metab</source>
                  <year>2008</year>
                  <volume>4</volume>
                  <issue>4</issue>
                  <fpage>200</fpage>
                  <lpage>213</lpage>
                  <pub-id pub-id-type="doi">10.1038/ncpendmet0778</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">18301398</pub-id>
                </element-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Shields</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Hammersley</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Systematic population screening, using biomarkers and genetic
testing, identifies 2.5% of the U.K. pediatric diabetes population
with monogenic diabetes</article-title>
                  <source>Diabetes Care</source>
                  <year>2016</year>
                  <comment>doi: dc160645 [pii]</comment>
                </element-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Weinreich</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Bosma</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Henneman</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A decade of molecular genetic testing for MODY: A retrospective
study of utilization in the netherlands</article-title>
                  <source>Eur J Hum Genet</source>
                  <year>2015</year>
                  <volume>23</volume>
                  <issue>1</issue>
                  <fpage>29</fpage>
                  <lpage>33</lpage>
                  <pub-id pub-id-type="doi">10.1038/ejhg.2014.59</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">24736738</pub-id>
                </element-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Delvecchio</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Ludovico</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Menzaghi</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Low prevalence of HNF1A mutations after molecular screening of
multiple MODY genes in 58 italian families recruited in the pediatric or
adult diabetes clinic from a single italian hospital</article-title>
                  <source>Diabetes Care</source>
                  <year>2014</year>
                  <volume>37</volume>
                  <issue>12</issue>
                  <fpage>e258</fpage>
                  <lpage>60</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc14-1788</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">25414397</pub-id>
                </element-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Naylor</surname>
                      <given-names>RN</given-names>
                    </name>
                    <name>
                      <surname>John</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Winn</surname>
                      <given-names>AN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cost-effectiveness of MODY genetic testing: Translating genomic
advances into practical health applications</article-title>
                  <source>Diabetes Care</source>
                  <year>2014</year>
                  <volume>37</volume>
                  <issue>1</issue>
                  <fpage>202</fpage>
                  <lpage>209</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc13-0410</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">24026547</pub-id>
                </element-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Shields</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rubio-Cabezas</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Hattersley</surname>
                      <given-names>AT</given-names>
                    </name>
                  </person-group>
                  <article-title>A genetic diagnosis of HNF1A diabetes alters treatment and
improves glycaemic control in the majority of insulin-treated
patients</article-title>
                  <source>Diabet Med</source>
                  <year>2009</year>
                  <volume>26</volume>
                  <issue>4</issue>
                  <fpage>437</fpage>
                  <lpage>441</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1464-5491.2009.02690.x</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">19388975</pub-id>
                </element-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pearson</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Pruhova</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tack</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Molecular genetics and phenotypic characteristics of MODY caused
by hepatocyte nuclear factor 4alpha mutations in a large european
collection</article-title>
                  <source>Diabetologia</source>
                  <year>2005</year>
                  <volume>48</volume>
                  <issue>5</issue>
                  <fpage>878</fpage>
                  <lpage>885</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-005-1738-y</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">15830177</pub-id>
                </element-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Steele</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Shields</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Wensley</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Colclough</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Hattersley</surname>
                      <given-names>AT</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence of vascular complications among patients with
glucokinase mutations and prolonged, mild hyperglycemia</article-title>
                  <source>JAMA</source>
                  <year>2014</year>
                  <volume>311</volume>
                  <issue>3</issue>
                  <fpage>279</fpage>
                  <lpage>286</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2013.283980</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">24430320</pub-id>
                </element-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <collab>American Diabetes Association</collab>
                  <article-title>2. classification and diagnosis of diabetes</article-title>
                  <source>Diabetes Care</source>
                  <year>2017</year>
                  <volume>40</volume>
                  <issue>Suppl 1</issue>
                  <fpage>S11</fpage>
                  <lpage>S24</lpage>
                  <comment>doi: 40/Supplement_1/S11 [pii]</comment>
                  <pub-id pub-id-type="pmid">27979889</pub-id>
                </element-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pihoker</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gilliam</surname>
                      <given-names>LK</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence, characteristics and clinical diagnosis of maturity
onset diabetes of the young due to mutations in HNF1A, HNF4A, and
glucokinase: Results from the SEARCH for diabetes in youth</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <year>2013</year>
                  <volume>98</volume>
                  <issue>10</issue>
                  <fpage>4055</fpage>
                  <lpage>4062</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2013-1279</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">23771925</pub-id>
                </element-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>TODAY Study Group</collab>
                    <name>
                      <surname>Zeitler</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Epstein</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Treatment options for type 2 diabetes in adolescents and youth: A
study of the comparative efficacy of metformin alone or in combination with
rosiglitazone or lifestyle intervention in adolescents with type 2
diabetes</article-title>
                  <source>Pediatr Diabetes</source>
                  <year>2007</year>
                  <volume>8</volume>
                  <issue>2</issue>
                  <fpage>74</fpage>
                  <lpage>87</lpage>
                  <comment>doi: PDI237 [pii]</comment>
                  <pub-id pub-id-type="pmid">17448130</pub-id>
                </element-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>TODAY Study Group</collab>
                    <name>
                      <surname>Zeitler</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Hirst</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A clinical trial to maintain glycemic control in youth with type
2 diabetes</article-title>
                  <source>N Engl J Med</source>
                  <year>2012</year>
                  <volume>366</volume>
                  <issue>24</issue>
                  <fpage>2247</fpage>
                  <lpage>2256</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1109333</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">22540912</pub-id>
                </element-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Richards</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Aziz</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Bale</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the american college of
medical genetics and genomics and the association for molecular
pathology</article-title>
                  <source>Genet Med</source>
                  <year>2015</year>
                  <volume>17</volume>
                  <issue>5</issue>
                  <fpage>405</fpage>
                  <lpage>423</lpage>
                  <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">25741868</pub-id>
                </element-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rothman</surname>
                      <given-names>KJ</given-names>
                    </name>
                  </person-group>
                  <article-title>No adjustments are needed for multiple
comparisons</article-title>
                  <source>Epidemiology</source>
                  <year>1990</year>
                  <volume>1</volume>
                  <issue>1</issue>
                  <fpage>43</fpage>
                  <lpage>46</lpage>
                  <pub-id pub-id-type="pmid">2081237</pub-id>
                </element-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <collab>Writing Group for the SEARCH for Diabetes in Youth Study
Group</collab>
                    <name>
                      <surname>Dabelea</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Bell</surname>
                      <given-names>RA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Incidence of diabetes in youth in the united
states</article-title>
                  <source>JAMA</source>
                  <year>2007</year>
                  <volume>297</volume>
                  <issue>24</issue>
                  <fpage>2716</fpage>
                  <lpage>2724</lpage>
                  <comment>doi:297/24/2716 [pii]</comment>
                  <pub-id pub-id-type="pmid">17595272</pub-id>
                </element-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDonald</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>Colclough</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Islet autoantibodies can discriminate maturity-onset diabetes of
the young (MODY) from type 1 diabetes</article-title>
                  <source>Diabet Med</source>
                  <year>2011</year>
                  <volume>28</volume>
                  <issue>9</issue>
                  <fpage>1028</fpage>
                  <lpage>1033</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1464-5491.2011.03287.x</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">21395678</pub-id>
                </element-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wheeler</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Patterson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Love</surname>
                      <given-names>DR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Frequency and genetic spectrum of maturity-onset diabetes of the
young (MODY) in southern new zealand</article-title>
                  <source>J Diabetes Metab Disord</source>
                  <year>2013</year>
                  <volume>12</volume>
                  <issue>1</issue>
                  <fpage>46</fpage>
                  <lpage>6581</lpage>
                  <fpage>12</fpage>
                  <lpage>46</lpage>
                  <pub-id pub-id-type="doi">10.1186/2251-6581-12-46</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">24355479</pub-id>
                </element-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chambers</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Fouts</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Characteristics of maturity onset diabetes of the young in a
large diabetes center</article-title>
                  <source>Pediatr Diabetes</source>
                  <year>2015</year>
                  <pub-id pub-id-type="doi">10.1111/pedi.12289</pub-id>
                  <comment>[doi]</comment>
                </element-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shields</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Hicks</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Colclough</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hattersley</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Maturity-onset diabetes of the young (MODY): How many cases are
we missing?</article-title>
                  <source>Diabetologia</source>
                  <year>2010</year>
                  <volume>53</volume>
                  <issue>12</issue>
                  <fpage>2504</fpage>
                  <lpage>2508</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00125-010-1799-4</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">20499044</pub-id>
                </element-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pearson</surname>
                      <given-names>ER</given-names>
                    </name>
                    <name>
                      <surname>Boj</surname>
                      <given-names>SF</given-names>
                    </name>
                    <name>
                      <surname>Steele</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Macrosomia and hyperinsulinaemic hypoglycaemia in patients with
heterozygous mutations in the HNF4A gene</article-title>
                  <source>PLoS Med</source>
                  <year>2007</year>
                  <volume>4</volume>
                  <issue>4</issue>
                  <fpage>e118</fpage>
                  <comment>doi: 06-PLME-RA-0685R2 [pii]</comment>
                  <pub-id pub-id-type="pmid">17407387</pub-id>
                </element-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fetal macrosomia and adolescence obesity: Results from a
longitudinal cohort study</article-title>
                  <source>Int J Obes (Lond)</source>
                  <year>2009</year>
                  <volume>33</volume>
                  <issue>8</issue>
                  <fpage>923</fpage>
                  <lpage>928</lpage>
                  <pub-id pub-id-type="doi">10.1038/ijo.2009.131</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">19564880</pub-id>
                </element-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stride</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Beta-cell dysfunction, insulin sensitivity, and glycosuria
precede diabetes in hepatocyte nuclear factor-1alpha mutation
carriers</article-title>
                  <source>Diabetes Care</source>
                  <year>2005</year>
                  <volume>28</volume>
                  <issue>7</issue>
                  <fpage>1751</fpage>
                  <lpage>1756</lpage>
                  <comment>doi:28/7/1751 [pii]</comment>
                  <pub-id pub-id-type="pmid">15983330</pub-id>
                </element-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fendler</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Rizzo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Borowiec</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Less but better: Cardioprotective lipid profile of patients with
GCK-MODY despite lower HDL cholesterol level</article-title>
                  <source>Acta Diabetol</source>
                  <year>2014</year>
                  <volume>51</volume>
                  <issue>4</issue>
                  <fpage>625</fpage>
                  <lpage>632</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00592-014-0567-1</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">24549415</pub-id>
                </element-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDonald</surname>
                      <given-names>TJ</given-names>
                    </name>
                    <name>
                      <surname>McEneny</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pearson</surname>
                      <given-names>ER</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Lipoprotein composition in HNF1A-MODY: Differentiating between
HNF1A-MODY and type 2 diabetes</article-title>
                  <source>Clin Chim Acta</source>
                  <year>2012</year>
                  <volume>413</volume>
                  <fpage>9</fpage>
                  <lpage>10</lpage>
                  <fpage>927</fpage>
                  <lpage>932</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cca.2012.02.005</pub-id>
                  <comment>[doi]</comment>
                </element-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Forlani</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Zucchini</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Di Rocco</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Double heterozygous mutations involving both HNF1A/MODY3 and
HNF4A/MODY1 genes: A case report</article-title>
                  <source>Diabetes Care</source>
                  <year>2010</year>
                  <volume>33</volume>
                  <issue>11</issue>
                  <fpage>2336</fpage>
                  <lpage>2338</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc10-0561</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">20705777</pub-id>
                </element-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Monney</surname>
                      <given-names>CT</given-names>
                    </name>
                    <name>
                      <surname>Kaltenrieder</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Cousin</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Bonny</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Schorderet</surname>
                      <given-names>DF</given-names>
                    </name>
                  </person-group>
                  <article-title>Large family with maturity-onset diabetes of the young and a
novel V121I mutation in HNF4A</article-title>
                  <source>Hum Mutat</source>
                  <year>2002</year>
                  <volume>20</volume>
                  <issue>3</issue>
                  <fpage>230</fpage>
                  <lpage>231</lpage>
                  <pub-id pub-id-type="doi">10.1002/humu.9050</pub-id>
                  <comment>[doi]</comment>
                </element-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gloyn</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Noordam</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Willemsen</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Insights into the biochemical and genetic basis of glucokinase
activation from naturally occurring hypoglycemia mutations</article-title>
                  <source>Diabetes</source>
                  <year>2003</year>
                  <volume>52</volume>
                  <issue>9</issue>
                  <fpage>2433</fpage>
                  <lpage>2440</lpage>
                  <pub-id pub-id-type="pmid">12941786</pub-id>
                </element-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Beards</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>LI</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A high prevalence of glucokinase mutations in gestational
diabetic subjects selected by clinical criteria</article-title>
                  <source>Diabetologia</source>
                  <year>2000</year>
                  <volume>43</volume>
                  <issue>2</issue>
                  <fpage>250</fpage>
                  <lpage>253</lpage>
                  <pub-id pub-id-type="doi">10.1007/s001250050038</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">10753050</pub-id>
                </element-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bertini</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Maioli</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Fresu</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Tonolo</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Pirastu</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maioli</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>A new missense mutation in the glucokinase gene in an italian
mody family</article-title>
                  <source>Diabetologia</source>
                  <year>1996</year>
                  <volume>39</volume>
                  <issue>11</issue>
                  <fpage>1413</fpage>
                  <lpage>1414</lpage>
                  <pub-id pub-id-type="pmid">8933019</pub-id>
                </element-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Osbak</surname>
                      <given-names>KK</given-names>
                    </name>
                    <name>
                      <surname>Colclough</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Saint-Martin</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Update on mutations in glucokinase (GCK), which cause
maturity-onset diabetes of the young, permanent neonatal diabetes, and
hyperinsulinemic hypoglycemia</article-title>
                  <source>Hum Mutat</source>
                  <year>2009</year>
                  <volume>30</volume>
                  <issue>11</issue>
                  <fpage>1512</fpage>
                  <lpage>1526</lpage>
                  <pub-id pub-id-type="doi">10.1002/humu.21110</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">19790256</pub-id>
                </element-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Galan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Vincent</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Roncero</surname>
                      <given-names>I</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of novel maturity-onset diabetes of the young
(MODY)-associated mutations on glucokinase activity and protein
stability</article-title>
                  <source>Biochem J</source>
                  <year>2006</year>
                  <volume>393</volume>
                  <issue>Pt 1</issue>
                  <fpage>389</fpage>
                  <lpage>396</lpage>
                  <comment>doi: BJ20051137 [pii]</comment>
                  <pub-id pub-id-type="pmid">16173921</pub-id>
                </element-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hattersley</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Beards</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Ballantyne</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Appleton</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Harvey</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Mutations in the glucokinase gene of the fetus result in reduced
birth weight</article-title>
                  <source>Nat Genet</source>
                  <year>1998</year>
                  <volume>19</volume>
                  <issue>3</issue>
                  <fpage>268</fpage>
                  <lpage>270</lpage>
                  <pub-id pub-id-type="doi">10.1038/953</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">9662401</pub-id>
                </element-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bjorkhaug</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Ye</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Horikawa</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sovik</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Molven</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Njolstad</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <article-title>MODY associated with two novel hepatocyte nuclear factor-1alpha
loss-of-function mutations (P112L and Q466X)</article-title>
                  <source>Biochem Biophys Res Commun</source>
                  <year>2000</year>
                  <volume>279</volume>
                  <issue>3</issue>
                  <fpage>792</fpage>
                  <lpage>798</lpage>
                  <pub-id pub-id-type="doi">10.1006/bbrc.2000.4024</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">11162430</pub-id>
                </element-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frayling</surname>
                      <given-names>TM</given-names>
                    </name>
                    <name>
                      <surname>Bulamn</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Ellard</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mutations in the hepatocyte nuclear factor-1alpha gene are a
common cause of maturity-onset diabetes of the young in the
UK</article-title>
                  <source>Diabetes</source>
                  <year>1997</year>
                  <volume>46</volume>
                  <issue>4</issue>
                  <fpage>720</fpage>
                  <lpage>725</lpage>
                  <pub-id pub-id-type="pmid">9075818</pub-id>
                </element-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Balamurugan</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Bjorkhaug</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Mahajan</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Structure – function studies of HNF1A (MODY3) gene
mutations in south indian patients with monogenic diabetes</article-title>
                  <source>Clin Genet</source>
                  <year>2016</year>
                  <pub-id pub-id-type="doi">10.1111/cge.12757</pub-id>
                  <comment>[doi]</comment>
                </element-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ekholm</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Nilsson</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Groop</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Pramfalk</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Alterations in bile acid synthesis in carriers of hepatocyte
nuclear factor 1alpha mutations</article-title>
                  <source>J Intern Med</source>
                  <year>2013</year>
                  <volume>274</volume>
                  <issue>3</issue>
                  <fpage>263</fpage>
                  <lpage>272</lpage>
                  <pub-id pub-id-type="doi">10.1111/joim.12082</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">23607861</pub-id>
                </element-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neve</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Fernandez-Zapico</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Ashkenazi-Katalan</surname>
                      <given-names>V</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Role of transcription factor KLF11 and its diabetes-associated
gene variants in pancreatic beta cell function</article-title>
                  <source>Proc Natl Acad Sci U S A</source>
                  <year>2005</year>
                  <volume>102</volume>
                  <issue>13</issue>
                  <fpage>4807</fpage>
                  <lpage>4812</lpage>
                  <comment>doi: 0409177102 [pii]</comment>
                  <pub-id pub-id-type="pmid">15774581</pub-id>
                </element-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boesgaard</surname>
                      <given-names>TW</given-names>
                    </name>
                    <name>
                      <surname>Pruhova</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Andersson</surname>
                      <given-names>EA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Further evidence that mutations in INS can be a rare cause of
maturity-onset diabetes of the young (MODY)</article-title>
                  <source>BMC Med Genet</source>
                  <year>2010</year>
                  <volume>11</volume>
                  <fpage>42</fpage>
                  <lpage>2350</lpage>
                  <fpage>11</fpage>
                  <lpage>42</lpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2350-11-42</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">20226046</pub-id>
                </element-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Molven</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ringdal</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Nordbo</surname>
                      <given-names>AM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mutations in the insulin gene can cause MODY and
autoantibody-negative type 1 diabetes</article-title>
                  <source>Diabetes</source>
                  <year>2008</year>
                  <volume>57</volume>
                  <issue>4</issue>
                  <fpage>1131</fpage>
                  <lpage>1135</lpage>
                  <pub-id pub-id-type="doi">10.2337/db07-1467</pub-id>
                  <comment>[doi]</comment>
                  <pub-id pub-id-type="pmid">18192540</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="F1" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Failure-free survival curve of MODY gene subtypes and unaffected patients. X-axis
is defined as post-baseline-visit days until start of failure interval. Events
are defined as elevated glycated hemoglobin (&gt;8.0%) over a
period of 6 months or the inability to wean the participant from insulin within
3 months after treatment initiation in the TODAY study. Hazard ratio for each
subtype: <italic>GCK</italic>-MODY HR= undefined (no events),
<italic>HNF1A</italic>-MODY HR=1.26 (0.40–4.02
95%CI) p=0.7, and <italic>HNF4A</italic>-MODY HR=5.03
(2.18–11.58 95%CI) p=0.0002.</p>
              </caption>
              <graphic xlink:href="nihms897685f1"/>
            </fig>
            <table-wrap id="T1" position="float" orientation="landscape">
              <label>Table 1</label>
              <caption>
                <p>Pathogenic or likely pathogenic MODY gene variants and TODAY study patient
data</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
                    <th valign="top" align="left" rowspan="1" colspan="1">Sex (age)</th>
                    <th valign="top" align="left" rowspan="1" colspan="1">Race/ethnicity<xref rid="TFN2" ref-type="table-fn">a</xref></th>
                    <th valign="top" align="left" rowspan="1" colspan="1">Treatment arm<xref rid="TFN3" ref-type="table-fn">b</xref></th>
                    <th valign="top" align="center" rowspan="1" colspan="1">TODAY primary outcome<xref rid="TFN4" ref-type="table-fn">c</xref></th>
                    <th valign="top" align="left" rowspan="1" colspan="1">Amino acid change / Site change<xref rid="TFN5" ref-type="table-fn">d</xref></th>
                    <th valign="top" align="left" rowspan="1" colspan="1">ACMG pathogenicity</th>
                    <th valign="top" align="left" rowspan="1" colspan="1">Prev. Studies</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (10)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R64Q</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R26" ref-type="bibr">26</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (12)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R64fs</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Novel</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHB</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.Q86X</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Novel</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.V105I</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R27" ref-type="bibr">27</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (14)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Splice-site (c.573+1G&gt;A)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R8" ref-type="bibr">8</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (16)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R308H</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R5" ref-type="bibr">5</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF4A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (14)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.H365fs</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Novel</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (10)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.V62M</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R28" ref-type="bibr">28</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R191W</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R29" ref-type="bibr">29</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (17)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.T206M</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R30" ref-type="bibr">30</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.N254H</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R31" ref-type="bibr">31</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (12)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.E265K</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R32" ref-type="bibr">32</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R392C</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R33" ref-type="bibr">33</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>GCK</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (13)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.S396fs</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Novel</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF1A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (12)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.P112L</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R34" ref-type="bibr">34</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF1A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (11)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHB</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R131W</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R35" ref-type="bibr">35</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF1A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (12)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R271Q</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R36" ref-type="bibr">36</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF1A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (14)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.P379A</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R37" ref-type="bibr">37</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>HNF1A</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (10)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Life</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.P519L</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R35" ref-type="bibr">35</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>KLF11</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (16)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">His.</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">+</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.A347S</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R38" ref-type="bibr">38</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>INS</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">F (12)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHB</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Metformin</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R6H</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R39" ref-type="bibr">39</xref>
                      </sup>
                    </td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <italic>INS</italic>
                    </td>
                    <td valign="top" align="left" rowspan="1" colspan="1">M (15)</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">NHW</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Met.+Ros.</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">−</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">p.R46Q</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <sup>
                        <xref rid="R40" ref-type="bibr">40</xref>
                      </sup>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p>Quality metrics for each variant can be found in <xref ref-type="supplementary-material" rid="SD1">Table S4</xref>.</p>
                </fn>
                <fn id="TFN2">
                  <label>a</label>
                  <p>Self-reported race/ethnicity: His.=Hispanic, NHW =
Non-Hispanic White, NHB = Non-Hispanic Black</p>
                </fn>
                <fn id="TFN3">
                  <label>b</label>
                  <p>TODAY clinical trial treatment arm: Met.+Ros. = Metformin and
rosiglitazone, Met.+Life = Metformin and lifestyle
intervention</p>
                </fn>
                <fn id="TFN4">
                  <label>c</label>
                  <p>TODAY clinical trial outcome: (−) = Patient did not reach
primary outcome (treatment failure), (+) = Patient reached
primary outcome (treatment failure)</p>
                </fn>
                <fn id="TFN5">
                  <label>d</label>
                  <p>Amino acid reported sites are according to the following reference sequences:
<italic>HNF4A</italic>-NM_001287183; NP_001274112,
<italic>GCK</italic>-NM_000162; NP_000153, <italic>HNF1A</italic>-NM_000545;
NP_000536, <italic>KLF11</italic>-NM_003597; NP_003588, and
<italic>INS</italic>-NM_000207; NP_000198.1</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="T2" position="float" orientation="landscape">
              <label>Table 2</label>
              <caption>
                <p>Associations between all monogenic diabetes variants, gene subtypes and patient
characteristics at earliest study timepoint (screening or baseline), adjusted
for age, sex, and race/ethnicity</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th valign="top" align="left" rowspan="1" colspan="1"/>
                    <th valign="top" align="center" rowspan="1" colspan="1">Unaffected</th>
                    <th valign="top" align="center" rowspan="1" colspan="1">All Monogenic Diabetes<xref rid="TFN8" ref-type="table-fn">b</xref></th>
                    <th valign="top" align="center" rowspan="1" colspan="1">HNF4A -MODY</th>
                    <th valign="top" align="center" rowspan="1" colspan="1">GCK-MODY</th>
                    <th valign="top" align="center" rowspan="1" colspan="1">HNF1A- MODY</th>
                    <th valign="top" align="center" rowspan="1" colspan="1">INS-MODY</th>
                    <th valign="top" align="center" rowspan="1" colspan="1">KLF11-MODY</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>n</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">426</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">22</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">5</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>BMI Z-score Mean ±
SD</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.32 ±0.42</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.05 ±0.42<xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.12 ±0.52</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.91 ±0.33 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.06 ±0.32</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.52 ±0.44</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.49</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>DXA fat %</bold>
                      <xref rid="TFN9" ref-type="table-fn">c</xref>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">38.3 ±6.02</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">35.2 ±6.9</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">38.4 ±7.0</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">38.3 ±5.7</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">29.9 ±1.5 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">30.6</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">23.9</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>HbA1c (%)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7.51 ±1.97</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7.45 ±1.93</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7.27 ±2.35</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.99 ±2.23</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7.78 ±1.03</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">9.40 ±0.57</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.4</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Fasting glucose (mmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.08 ±1.27</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.65 ±1.56<xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">7.15 ±1.09 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.69 ±0.28</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">5.46 ±1.2</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">5.22 ±0.24</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">11.6</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Fasting insulin (pmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">213.9 ±145.3</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">152.1 ±210.0 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">122.2 ±46.3</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">87.5 ±32.7 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">107.6 ±7.5<xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">588.9 ±679.7</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">164.6</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1"><bold>Insulinogenic
index</bold><break/>(Ins<sub>30-0</sub>/Glu<sub>30-0</sub>)</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.63 ±2.45</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">0.81 ±0.84</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">0.56 ±0.41</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.28 ±1.24</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">0.49 ±0.17</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.29</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Systolic blood pressure
(mmHg)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">113.8 ±11.4</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">107.9 ±13.6</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">113.1 ±16.5</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">99.4 ±9.4 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">107.6 ±7.5</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">119.8 ±22.3</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">109</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Diastolic blood pressure
(mmHg)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">67.2 ±8.8</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">64.3 ±9.7</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">67.1 ±12.0</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">60.9 ±11.3</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">64.7 ±5.4</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">66.3 ±8.1</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">63.5</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Total cholesterol (mmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">3.98 ±0.86</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">4.50 ±1.06<xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">4.77 ±1.15 <xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">4.11 ±0.9</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">4.38 ±1.08</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">4.26 ±0.68</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.4</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>HDL cholesterol (mmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.03 ±0.24</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.09 ±0.24</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.19 ±0.21</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.05 ±0.34</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.03 ±0.12</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.18 ±0.20</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">0.83</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>LDL cholesterol (mmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.33 ±0.72</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.65 ±0.72<xref rid="TFN7" ref-type="table-fn">a</xref></td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.82 ±0.96</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.48 ±0.68</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.56 ±0.47</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">2.51 ±0.84</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">3.34</td>
                  </tr>
                  <tr>
                    <td valign="top" align="left" rowspan="1" colspan="1">
                      <bold>Triglycerides (mmol/L)</bold>
                    </td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.38 ±0.91</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.71 ±1.30</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.66 ±0.77</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.27 ±0.79</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.72 ±1.32</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">1.23 ±0.07</td>
                    <td valign="top" align="center" rowspan="1" colspan="1">6.09</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN6">
                  <p>Values are presented as mean ±SD. All measures were taken at
screening in the TODAY study, except for fasting glucose, fasting insulin,
insulinogenic index and DXA fat measures, which were taken at the baseline
time-point.</p>
                </fn>
                <fn id="TFN7">
                  <label>a</label>
                  <p>p&lt;0.05 for the effect size of the classification (monogenic diabetes
status in aggregate or separated by gene) in a linear model accounting for
sex, age, and race/ethnicity (effect sizes, BMI Z-score adjusted results,
and p-values found in <xref ref-type="supplementary-material" rid="SD1">Table S9</xref>)</p>
                </fn>
                <fn id="TFN8">
                  <label>b</label>
                  <p>Monogenic diabetes Pathogenic or Likely Pathogenic Mutation</p>
                </fn>
                <fn id="TFN9">
                  <label>c</label>
                  <p>DXA data was available for 303 unaffected individuals and 15 patients with
monogenic diabetes (5 <italic>HNF4A</italic>-MODY, 5
<italic>GCK</italic>-MODY, 3 <italic>HNF1A</italic>-MODY, 1
<italic>INS</italic>-MODY, and 1 <italic>KLF11</italic>-MODY).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
